Unique Properties of Synaptosomes and Prospects for Their Use for the Treatment of Neurodegenerative Diseases (Review) DOI

Alla S Dashkova,

V. I. Kovalev,

A. V. Chaplygina

et al.

Биохимия, Journal Year: 2024, Volume and Issue: 89(6), P. 1015 - 1030

Published: Dec. 25, 2024

Alzheimer’s disease (AD) is a severe neurodegenerative that affects millions of people around the world. The increasing prevalence AD correlates with life expectancy and aging populations in developed countries. Since multifactorial includes various pathological processes, such as: synaptic dysfunction, neuroinflammation, oxidative stress, protein misfolding, etc., an integrated approach aimed simultaneously at several targets may be effective slow down progression disease. Cell therapy its further development form transplantation cellular vesicles especially mitochondria are very promising for treatment neurodegeneration. use synaptosomes, due to uniqueness their content, become new stage complex diseases particular. This review discusses preparation composition as well possibilities advantages transporters delivery other biologically active substances brain.

Language: Английский

Synaptic Mitochondria: a crucial factor in the aged hippocampus DOI

Karina A Cicali,

Cheril Tapia‐Rojas

Ageing Research Reviews, Journal Year: 2024, Volume and Issue: unknown, P. 102524 - 102524

Published: Oct. 1, 2024

Language: Английский

Citations

4

Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits DOI Open Access
Joyce Yip, Grace Shu Hui Chiang,

I Lee

et al.

International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(1), P. 364 - 364

Published: Jan. 3, 2025

This review describes our current understanding of the role mitochondria in repurposing anti-diabetes drugs metformin, gliclazide, GLP-1 receptor agonists, and SGLT2 inhibitors for additional clinical benefits regarding unhealthy aging, long COVID, mental neurogenerative disorders, obesity. Metformin, most prominent these diabetes drugs, has been called “Drug Miracles Wonders,” as trials have found it to be beneficial human patients suffering from maladies. To promote viral replication all infected cells, SARS-CoV-2 stimulates liver cells produce glucose export into blood stream, which can cause COVID patients, reduces levels blood, was shown cut incidence rate half recovering SARS-CoV-2. Metformin leads phosphorylation AMP-activated protein kinase AMPK, accelerates import via transporter GLUT4 switches starvation mode, counteracting virus. Diabetes also stimulate unfolded response thus mitophagy, is healthy aging health. were mimic exercise help reduce body weight.

Language: Английский

Citations

0

Beneficial Effects of the Herbal Medicine Zuo Gui Wan in a Mice Model of Alzheimer's Disease via Drp1-Mediated Inhibition of Mitochondrial Fission and Activation of AMPK/PGC-1α-regulated Mitochondrial Bioenergetics DOI

Xirui Yan,

Yifang Yang, Weilin Huang

et al.

Journal of Ethnopharmacology, Journal Year: 2025, Volume and Issue: unknown, P. 119425 - 119425

Published: Jan. 1, 2025

Language: Английский

Citations

0

Pharmacological Targeting of the NMDAR/TRPM4 Death Signaling Complex with a TwinF Interface Inhibitor Prevents Excitotoxicity-Associated Dendritic Blebbing and Organelle Damage DOI Creative Commons
Omar A. Ramírez, Andrea Hellwig, Zihong Zhang

et al.

Cells, Journal Year: 2025, Volume and Issue: 14(3), P. 195 - 195

Published: Jan. 28, 2025

Focal swellings of dendrites (“dendritic blebbing”) together with structural damage mitochondria and the endoplasmic reticulum (ER) are morphological hallmarks glutamate neurotoxicity, also known as excitotoxicity. These pathological alterations generally thought to be caused by so-called “overactivation” N-methyl-D-aspartate receptors (NMDARs). Here, we demonstrate that activation extrasynaptic NMDARs, specifically when forming a protein–protein complex TRPM4, drives these traits. In contrast, strong synaptic NMDARs fails induce cell despite evoking plateau-type calcium signals comparable those generated NMDAR/TRPM4 complex, indicating high intracellular levels per se not toxic neurons. Using confocal laser scanning microscopy transmission electron microscopy, show disrupting using recently discovered small-molecule TwinF interface inhibitor FP802 inhibits NMDA-induced neurotoxicity-associated dendritic blebbing ER. It prevents, at least in part, disruption ER–mitochondria contact sites. findings establish trigger for organelles associated They suggest addition inducing high-amplitude, signals, generates second signal required neurotoxicity (“two-hit hypothesis”). As organelles, particularly mitochondria, is common feature many human neurodegenerative diseases, including Alzheimer’s disease amyotrophic lateral sclerosis (ALS), inhibitors have potential provide neuroprotection across broad spectrum diseases.

Language: Английский

Citations

0

Voluntary wheel exercise improves learning and memory impairment caused by hippocampal Hb-α deficiency by reducing microglial activation and reversing synaptic damage DOI
Yiying Wang,

Yuning Zhou,

Shun Wang

et al.

Brain Behavior and Immunity, Journal Year: 2025, Volume and Issue: 127, P. 81 - 95

Published: March 7, 2025

Language: Английский

Citations

0

Mitochondrial Genome Variants and Alzheimer’s Disease DOI
М. С. Козин, О. Г. Кулакова, Ivan Kiselev

et al.

Biochemistry (Moscow), Journal Year: 2025, Volume and Issue: 90(S1), P. S146 - S163

Published: Feb. 1, 2025

Language: Английский

Citations

0

Microvesicles carrying EV71 virions cross BBB through endocytic pathway to induce brain injury DOI Creative Commons

Xiaoyan Tian,

Bingxin Liu,

Linrun Li

et al.

Cell Communication and Signaling, Journal Year: 2025, Volume and Issue: 23(1)

Published: April 14, 2025

Language: Английский

Citations

0

Bezafibrate confers neuroprotection in the 5xFAD mouse model of Alzheimer's disease DOI Creative Commons
Yubing Lu, Hisashi Fujioka, Wenzhang Wang

et al.

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Journal Year: 2023, Volume and Issue: 1869(8), P. 166841 - 166841

Published: Aug. 7, 2023

Language: Английский

Citations

10

α-Synuclein propagation leads to synaptic abnormalities in the cortex through microglial synapse phagocytosis DOI Creative Commons
Dayana Pérez-Acuña,

Soo Jean Shin,

Ka Hyun Rhee

et al.

Molecular Brain, Journal Year: 2023, Volume and Issue: 16(1)

Published: Oct. 17, 2023

The major neuropathologic feature of Parkinson's disease is the presence widespread intracellular inclusions α-synuclein known as Lewy bodies. Evidence suggests that these misfolded protein spread through brain with progression. Changes in synaptic function precede neurodegeneration, and this extracellular can affect transmission. However, whether how spreading aggregates modulates before neuronal loss remains unknown. In present study, we investigated effect intrastriatal injection preformed fibrils (PFFs) on activity somatosensory cortex using a combination whole-cell patch-clamp electrophysiology, histology, Golgi-Cox staining. Intrastriatal PFF was followed by formation phosphorylated layer 5 cortex, leading to decrease synapse density, dendritic spines, spontaneous excitatory post-synaptic currents, without apparent loss. Additionally, three-dimensional reconstruction microglia confocal imaging showed an increase engulfment synapses. Collectively, our data indicate propagation neural networks causes abnormalities structure dynamics prior

Language: Английский

Citations

9

Unique Properties of Synaptosomes and Prospects for Their Use for the Treatment of Alzheimer’s Disease DOI

Alla S Dashkova,

Vladimir Igorevich Kovalev,

A. V. Chaplygina

et al.

Biochemistry (Moscow), Journal Year: 2024, Volume and Issue: 89(6), P. 1031 - 1044

Published: June 1, 2024

Language: Английский

Citations

3